Literature DB >> 2185118

Interactions between analgesics and calcium channel blockers.

H F Miranda1, C Paeile.   

Abstract

1. The findings, derived from different experimental models, examined in this review, provide evidence that the calcium channel blockers and related drugs possess analgesic effects. 2. The antinociceptive action that some analgesic drugs exhibit may be related to calcium channel blockade. 3. Evidence from a variety of biochemical and pharmacological experimental approaches, support the existence of an interelation between the calcium modulators and the opioid drugs. 4. This idea agrees with the novel neuropharmacological hypothesis that a common very high affinity binding site for multiple neurotransmitters could exist, as has been proposed by Pasternak and Wood (1986). 5. This hypothesis could be extended to the neuromodulators or other neuromediators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185118     DOI: 10.1016/0306-3623(90)90896-t

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  5 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Modulation of nicotine-induced analgesia by calcium agonist and antagonist in adult rats.

Authors:  C W Chin; R C Block; W H Wu; V K Zbuzek
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice.

Authors:  Jian-Hui Liang; Xu-Hua Wang; Rui-Ke Liu; Hong-Lei Sun; Xiang-Feng Ye; Ji-Wang Zheng
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

4.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

5.  Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools.

Authors:  Xiaoyu Pan; Jiechun Chen; Weijie Wang; Ling Chen; Lin Wang; Quan Ma; Jianbo Zhang; Lichao Chen; Gang Wang; Meixi Zhang; Hao Wu; Ruochuan Cheng
Journal:  Oncotarget       Date:  2017-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.